Additional registration fees may apply. A Categorical seminar is included for Weekend Only Attendees. *Members who are also members of a Council or Center will receive a $20 discount when registering online for a Physician/Scientist Categorical.
SNMMI's Annual Meeting offers full-day categorical seminars to provide you with a deeper level of understanding as you examine a single topic of clinical, scientific, or academic interest.
Sponsored by the Therapy Center of Excellence
Nuclear Medicine performs more I-131 therapies than all other nuclear medicine therapies combined. The ATA (American Thyroid Association) 2015 guidelines has 34 recommendations that affect the practice of nuclear medicine involving the imaging and therapy of thyroid nodules and differentiated thyroid cancer.
Sponsored by the General Clinical Nuclear Medicine Council
This comprehensive session is designed for imaging specialists, investigators, technologists, and clinicians who want both a review of the current status of molecular imaging of inflammation and infection, as well as an update on new and emerging developments in the field. This seminar will include reviews of currently available single photon and positron emitting radiopharmaceuticals—including their indications, advantages and disadvantages, and pitfalls in imaging infection and inflammation. The role of molecular imaging in inflammatory arthritis, atherosclerosis & vulnerable plaque, tuberculosis, and musculoskeletal infection will be addressed. This seminar also will cover recent advances in the use of molecular imaging for monitoring treatment response, the development of new radiopharmaceuticals for imaging inflammation and infection, including infection specific agents, and PET/MR. Molecular Imaging of infection and inflammation is a very broad field, with numerous novel and innovative developments in imaging for diagnosis and prognosis. While it is not possible, even with a full day seminar, to cover the entire field, this categorical seminar will cover many important topics not previously addressed.
Sponsored by the Theranostics Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), ENTS Center of Excellence
In this categorical seminar, participants will assess the current state-of-the-art options for therapy of end stage prostate cancer. This seminar will explore a broad spectrum of the use of PSMA ligands for therapy of prostate cancer, including radiochemical aspects, preclinical studies, the role of PSMA PET/CT (using Ga68 and F-18) clinical utility, and the state-of-the-art role including newer radionuclides and alpha targeted radioligand therapy.
Sponsored by the Computer and Instrumentation Council and the Center for Molecular Imaging Innovation and Translation
In this categorical seminar, participants will receive a general introduction and more in-depth discussion into the emerging fields of radiomics and machine learning as applied to imaging, including an overview of various applications in nuclear medicine. The seminar will provide both a foundational overview for the methodology and significant success of the field of machine learning in general, and how these methods are increasingly applied in imaging including anatomic radiology and nuclear medicine/molecular imaging. Various applications will be discussed, including emphasis on oncological PET imaging. Discussions will also include the field of radiogenomics (imaging genetics), and how combination of radiomic and genomic features hold promise towards derivation of effective biomarkers of disease.
Sponsored by the Cardiovascular Council
This categorical seminar will offer cardiovascular imaging specialists and clinicians, scientists, technologists, and trainees with a case-based, interactive and multimodality presentation to increase understanding of advanced multimodality cardiovascular imaging as applied to coronary artery disease, congestive heart failure and inflammation and infection. Through these case presentations, participants will gain a better understanding of advanced multimodality cardiovascular imaging, and improve their ability to incorporate test results into clinical reports and patient management. In addition, patient outcomes will improve with understanding of the strengths and limitations of imaging and role of imaging in decisions about patient management.
Sponsored by the Brain Imaging Council
The field of molecular neuroimaging has been developing rapidly in the recent years. Numerous novel tracers have been introduced ranging from approved tracers for imaging amyloid-depositions to novel tracers for tau-aggregates or synaptic function. Finally, novel imaging procedures allow to monitor complex system neuropathologies, including inflammation, which may underlie numerous disorders of the central nervous system rather than one particular type of disease. In this categorical seminar, participants will examine how molecular imaging of such processes may be beneficial for research and clinical applications. The seminar will also explore how new options can be potentially applied to solve clinical questions, including the advances in tracer development accompanied by methodological progress in instrumentation such as integrated PET/MR, and new methods for image processing including artificial intelligence approaches.
Sponsored by the PET Center of Excellence, Pediatric Imaging Council, and Computer and Instrumentation Council
This categorical seminar will provide practitioners—physicians, physicists/ scientists, technologists and resident/ students— with a practical nuts and bolts review of clinical PET/CT and PET/MR. The seminar will feature new technological developments in PET/CT and PET/MR instrumentation and the emerging role of machine learning, choosing and optimizing PET/CT and PET/MR protocols, and explore practical approaches to radiation dose reduction. Advanced concepts will also be addressed, including an approach to PET/CT and PET/MR with newly FDG-approved radiotracers, as well as updates in brain PET, myocardial PET, prostate PET and neuroendocrine PET.
Sponsored by the MIRD Committee
This categorical seminar will introduce the recently updated MIRD Committee Primer on Dosimetry. A series of sessions will be presented that correspond to the different primer chapters. Participants will review the MIRD schema for dosimetry including application to both macroscopic organs, cell-level calculations and it’s use in both therapy and diagnosis. Measurements required for dosimetry will be discussed. Dosimetry, forms and rules for investigational human use as well an overview of the various forms required by international, US and institutional regulatory and compliance bodies will be examined.